HIGHMARK, INC. for HIGHMARK INC
What was lobbied
5 issue areas, each in the filer's own words, with who lobbied on it and where.
Taxation/Internal Revenue Code TAX
Health Insurance Tax; Cadillac tax HR 928 Introduced February 12, 2015 by Charles Boustany (R-LA) To repeal the annual fee on health insurance providers enacted by the Patient Protection and Affordable Care Act. S 183 Introduced January 16, 2015 by John Barrasso (R-WY) Jobs and Premium Protection Act This bill repeals a provision of the Patient Protection and Affordable Care Act that imposes an annual fee on a health insurance provider based on its net premium income.
| Lobbyist | Covered position, as disclosed |
|---|---|
| GREGORY P ENGLERT | — |
| MICHAEL G WARFEL | — |
Medicare/Medicaid MMM
Medicare/Medicaid Issues: Medigap; Medicare Advantage; Site-Neutral Payments
| Lobbyist | Covered position, as disclosed |
|---|---|
| GREGORY P ENGLERT | — |
| MICHAEL G WARFEL | — |
Budget/Appropriations BUD
ACA Risk Corridors.
| Lobbyist | Covered position, as disclosed |
|---|---|
| GREGORY P ENGLERT | — |
| MICHAEL G WARFEL | — |
Health Issues HCR
Affordable Care Act; Delivery System Reform; Implementation; Small Group Expansion; Opioid Abuse; Medical Loss Ratios; Exchanges; Payment Reform; Plan Innovation; ACA Regulations; Risk Corridors; Site-Neutral Payments HR 928 Introduced February 12, 2015 by Charles Boustany (R-LA) This bill repeals a provision of the Patient Protection and Affordable Care Act that imposes an annual fee on a health insurance provider based on its net premium income. HR 1624 Introduced March 25, 2015 by Brett Guthrie (R-KY) To amend title I of the Patient Protection and Affordable Care Act and title XXVII of the Public Health Service Act to revise the definition of small employer. S. 1099 Introduced April 27, 2015 by Tim Scott (R-SC) A bill to amend the Patient Protection and Affordable Care Act to provide States with flexibility in determining the size of employers in the small group market.
| Lobbyist | Covered position, as disclosed |
|---|---|
| GREGORY P ENGLERT | — |
| MICHAEL G WARFEL | — |
Pharmacy PHA
Pharmaceutical Innovation; Specialty Drug Costs; Opioid Abuse; Pharmacy lock-in legislation
| Lobbyist | Covered position, as disclosed |
|---|---|
| GREGORY P ENGLERT | — |
| MICHAEL G WARFEL | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.